The influence of heparin's molecular weight and the incidence of delayed type hypersensitivity reactions revisited; in response to Grims et al., Br J Dermatol 2007; 157:514-17.
Ludwig
R J
RJ
Schindewolf
M
M
Lindhoff-Last
E
E
Boehncke
W-H
WH
D000925:Anticoagulants / Q000009:adverse effects*; D003429:Cross Reactions / Q000187:drug effects; D003875:Drug Eruptions; D006495:Heparin, Low-Molecular-Weight / Q000009:adverse effects*; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000209:etiology*
D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight